OTCMKTS:BAYRY Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis $8.01 -0.04 (-0.50%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$8.00▼$8.1250-Day Range$6.83▼$8.0652-Week Range$6.82▼$13.82Volume423,634 shsAverage Volume1.50 million shsMarket Capitalization$31.48 billionP/E RatioN/ADividend Yield0.25%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Get Bayer Aktiengesellschaft alerts: Email Address Ad Porter & CompanyTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…Go here now to watch my new documentary About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.Read More BAYRY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BAYRY Stock News HeadlinesSeptember 6 at 7:05 PM | sports.yahoo.comJonathan Tah confirms he will not extend his contract at Bayer LeverkusenSeptember 5 at 7:42 AM | sports.yahoo.comThree Bayer Leverkusen players nominated for the Ballon d’OrSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…September 3, 2024 | americanbankingnews.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Significant Drop in Short InterestSeptember 2, 2024 | markets.businessinsider.comUBS Remains a Hold on Bayer (0P6S)September 2, 2024 | markets.businessinsider.comBayer (0P6S) Receives a Hold from J.P. MorganSeptember 1, 2024 | bloomberg.comBayer Kidney Drug Treats Common Form of Heart Failure in StudyAugust 31, 2024 | sports.yahoo.comPLAYER RATINGS | Bayer Leverkusen 2-3 RB LeipzigSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…August 31, 2024 | bbc.comBundesliga Bayer Leverkusen 2 RB Leipzig 3 Full timeAugust 31, 2024 | washingtonpost.comBayer Leverkusen beaten in the Bundesliga for first time in 15 months by LeipzigAugust 31, 2024 | sports.yahoo.comBayern Munich decide against signing Bayer Leverkusen defender Jonathan TahAugust 29, 2024 | sports.yahoo.comBayern Munich rejoin Barcelona in the race for Bayer Leverkusen centre-back Jonathan TahAugust 28, 2024 | markets.businessinsider.comBayer, NextRNA Therapeutics Enter Collaboration And License Agreement - Quick FactsAugust 28, 2024 | bizjournals.comBoston biotech signs deal with Bayer worth up to $547MAugust 26, 2024 | sports.yahoo.comBarcelona tipped to launch surprise late-window move for Bayer Leverkusen starAugust 26, 2024 | businesswire.comFast, Stable, Secure: New Bayer Hardware Simplifies Farm Activities, Equipment Setup and Provides Increased Value to FarmersAugust 25, 2024 | sports.yahoo.com📸 Bayer Leverkusen begin Bundesliga title defence in typical style 💥See More Headlines Receive BAYRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/06/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:BAYRY CUSIPN/A CIK1144145 Webwww.bayer.com Phone49214301Fax49-21-4306-6328Employees99,723Year Founded1863Profitability EPS (Most Recent Fiscal Year)($0.87) Trailing P/E RatioN/A Forward P/E Ratio5.85 P/E GrowthN/ANet Income$-3,183,040,000.00 Net Margins-2.74% Pretax Margin-3.37% Return on Equity16.96% Return on Assets4.95% Debt Debt-to-Equity Ratio1.04 Current Ratio1.27 Quick Ratio0.86 Sales & Book Value Annual Sales$51.55 billion Price / Sales0.61 Cash Flow$3.99 per share Price / Cash Flow2.01 Book Value$10.44 per share Price / Book0.77Miscellaneous Outstanding Shares3,929,700,000Free FloatN/AMarket Cap$31.48 billion OptionableNot Optionable Beta1.04 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. William N. Anderson (Age 58)Chairman of the Management Board & CEO Comp: $9.16MMr. Wolfgang U. Nickl (Age 55)CFO & Member of Management Board Comp: $2.15MMr. Heiko W. J. Schipper (Age 55)Member of Management Board & President of the Consumer Health Division Comp: $2.11MMr. Stefan Oelrich (Age 56)Head of the Pharmaceuticals Division & Member of the Board of Management Comp: $2.11MMr. Rodrigo Santos (Age 51)Member of Management Board & President of the Crop Science Division Comp: $2.35MMs. Heike Prinz (Age 60)Chief Talent Officer, Labor Director & Member of Management Board Comp: $1.44MMr. Julio Triana (Age 58)Member of Management Board & President of Consumer Health Division Dr. Sebastian Guth Ph.D.Chief Operating OfficerDr. Jost Reinhard (Age 52)Head of Investor Relations Mr. Michael PreussHead of Communications, Government Relations and Corporate BrandMore ExecutivesKey CompetitorsRegeneron PharmaceuticalsNASDAQ:REGNVertex PharmaceuticalsNASDAQ:VRTXBristol-Myers SquibbNYSE:BMYCSLOTCMKTS:CSLLYGSKNYSE:GSKView All Competitors BAYRY Stock Analysis - Frequently Asked Questions How have BAYRY shares performed this year? Bayer Aktiengesellschaft's stock was trading at $9.23 on January 1st, 2024. Since then, BAYRY shares have decreased by 13.2% and is now trading at $8.0101. View the best growth stocks for 2024 here. How were Bayer Aktiengesellschaft's earnings last quarter? Bayer Aktiengesellschaft (OTCMKTS:BAYRY) issued its quarterly earnings results on Tuesday, August, 6th. The company reported $0.25 EPS for the quarter, meeting analysts' consensus estimates of $0.25. The company had revenue of $12 billion for the quarter. Bayer Aktiengesellschaft had a negative net margin of 2.74% and a positive trailing twelve-month return on equity of 16.96%. Does Bayer Aktiengesellschaft have any subsidiaries? Bayer Aktiengesellschaft subsidiaries include these companies: Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and more. How do I buy shares of Bayer Aktiengesellschaft? Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BAYRY) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bayer Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Bayer Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.